Skip to content

Clinical trials

Recruiting Carcinoma, Renal Cell trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Status: Recruiting Country / region: South Korea Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20192
20213
20222
20231
20241
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GI Innovation, Inc.3
Merck Sharp & Dohme LLC3
Yonsei University3
Arcus Biosciences, Inc.1
AstraZeneca1
Bristol-Myers Squibb1
Calico Life Sciences LLC1
GeneMedicine Co., Ltd.1
Hutom Corp1
Inhibrx Biosciences, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell18
Melanoma5
Squamous Cell Carcinoma of Head and Neck5
Carcinoma, Non-Small-Cell Lung4
Neoplasm Metastasis4
Neoplasms4
Colorectal Neoplasms3
Stomach Neoplasms3
Urinary Bladder Neoplasms3
Uterine Cervical Neoplasms3

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.